Showing 591-600 of 2158 results for "".
MATV News: Restylane Kysse Approval; Revance Acquires HintMD; Cutera Honors Heroes
https://beta.modernaesthetics.com/series/matv-news/matv-news-restylane-kysse-approval-revance-acquires-hintmd-cutera-honors-heroes/33567/MATV News: Restylane Kysse gets the FDA nod for lips; Revance to acquire HintMD, a a financial technology platform for the aesthetics industry; Cutera looks to honor COVID-19 heroes with new campaign, and The Aesthetic Society names its new board.MATV News: Revance DAXI News; CSF 2019 Highlights; miRing Device; ISAPS Stats
https://beta.modernaesthetics.com/series/matv-news/matv-news-revance-daxi-news-csf-2019-highlights-miring-device-isaps-stats/33515/Revance Therapeutics long-acting neuromodulator is now one step closer to FDA approval, Dr. Joel L. Cohen hosts coverage of Cosmetic Surgery Forum, and a new medical device is catching some buzz in the medical community. Plus, a look at annual statistics from the International Society of Aesthetic PMATV News: Vansanity Offers Shared Aesthetic Office Space; Juvéderm Voluma Update; Telemedicine in Plastic Surgery, More
https://beta.modernaesthetics.com/series/matv-news/matv-news-vansanity-offers-shared-aesthetic-office-space-juv-derm-voluma-update-telemedicine-in-plastic-surgery-more---srtejeci/33496/Vansanity offers shared office space for aesthetic providers, Juvéderm Voluma now approved for cheek augmentation in the mid-face with cannula, recent study assesses benefits of telemedicine in plastic surgery follow-up care; and Viola Davis signs on as spokesperson for L'Oreal Paris. Plus, is it tiTrends in Aesthetics: What Your Patients Want Now
https://beta.modernaesthetics.com/series/matv-news/trends-in-aesthetics-what-your-patients-want-now/33502/Combination treatments can enhance the patient experience, says New York Plastic Surgeon Bryan G. Forley, MD. He recently sat down with MATV to discuss current trends in minimally invasive procedures, tips for achieving the natural results patients are seeking from injectables, and when surgery mayMATV News: ISHRS Public Awareness Campaign; Obagi Focuses on Diversity; AIS Updates
https://beta.modernaesthetics.com/series/matv-news/matv-news-ishrs-public-awareness-campaign-obagi-focuses-on-diversiy-ais-updates/33482/ISHRS is launching a new public awareness campaign to help patients recognize “black market” hair restoration clinics, Obagi kicked off its Skinclusion initiative, and AIS attendees collaborate on the development and adoption of new aesthetic treatments and technologies. Plus, the FDA has accepted tMATV News: Plastic Surgery Resident Demographics, Emepelle Launch, Investigational Cellulite Treatment
https://beta.modernaesthetics.com/series/matv-news/matv-news-plastic-surgery-resident-demographics-emepelle-launch-investigational-cellulite-treatment/33470/Study finds that while the proportion of women entering plastic surgery residency programs has increased in recent years, numbers of Black and Hispanic trainees are declining or unchanged. ASPS reports uptick in plastic surgery procedures, Biopelle launches Emepelle, Endo shares positive data for inMATV News: The Medical Spa Show Updates; Jeuveau Approved; Millennials and Prejuvenation
https://beta.modernaesthetics.com/series/matv-news/matv-news-the-medical-spa-show-updates-jeuveau-approved-millennials-and-prejuvenation/33466/Study finds loss of volume, not just sagging, is responsible for aging upper lips, updates from AmSpa's Medical Spa Show 2019, the FDA approves new neurotoxin Jeuveau from Evolus, and Becton, Dickinson and Company unveils new glass pre-fillable syringe. Plus, why are millennials so into prejuvenatioMATV News: Restylane Lyft with Cannula Approved, New AAFPRS President, Plastic Surgery Trends
https://beta.modernaesthetics.com/series/matv-news/matv-news-restylane-lyft-with-cannula-approved-new-aafprs-president-plastic-surgery-trends/33253/The FDA has approved the use of Restylane Lyft with a small, blunt-tip cannula for cheek augmentation and midface contour deficiencies, Dr. Phillip R. Langsdon is the new President of The American Academy of Facial Plastic and Reconstructive Surgery, and a new study looks at how aging affects facialMATV News: RealSelf Worth It Ratings; Cutera and Candela Launches; FDA Approves Qbrexza
https://beta.modernaesthetics.com/series/matv-news/matv-news-realself-worth-it-ratings-cutera-and-candela-launches-fda-approves-qbrexza/33264/Demand for fat reduction and interest in vaginal rejuvenation at all-time high, RealSelf reports, Cutera and Candela both launch new devices, and there's a new FDA-approved treatment for hyperhidrosis. Plus, find out how the first #RealDealAesthetics Twitter Chat went, and share your thoughts on choVASER: Targeting Fat; Redefining Success
https://modernaesthetics.com/ma-supplements/2018-mar-apr-supplement/vaser-targeting-fat-redefining-success/34168/A safe and versatile system, VASER is reshaping the approach to fat reduction and body contouring.